nitazoxanide has been researched along with Leishmaniasis, Visceral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mesquita, JT; Reimão, JQ; Tempone, AG | 1 |
| Gao, H; Jin, H; Liu, Q; Ma, C; Shang, L; Wei, F; Wu, Y; Xia, Z; Zhang, R; Zhu, XQ | 1 |
2 other study(ies) available for nitazoxanide and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles | 2014 |
In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani.
Topics: Animals; Antiprotozoal Agents; Female; Leishmania donovani; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nitro Compounds; Spleen; Thiazoles; Treatment Outcome | 2010 |